EUVIMEDEUVIMED entdecken
Open Access

Luteolin decreases sFlt-1 and mean arterial pressure in the RUPP animal model of placental ischemia

Adrian C Eddy, Bhavisha A Bakrania, Weiwei Yang, Augustine Rajakumar, Eric M George, Joey P Granger, Sarosh Rana

Placenta · 2026

DOI: 10.1016/j.placenta.2026.06.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Placenta, 2026. Verfasst von Adrian C Eddy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL, USA. Hauptthemen laut MEDLINE: Luteolin, Vascular Endothelial Growth Factor Receptor-1, Ischemia, Arterial Pressure. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS, National Heart Lung and Blood Institute Division of Intramural Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Preeclampsia (PE) is a complication of pregnancy and a leading cause of maternal and fetal morbidity and mortality. Despite being prevalent and highly morbid, there are no approved treatments to relieve PE signs and symptoms. Many studies have established that elevated levels of circulating anti-angiogenic soluble fms-like tyrosine kinase 1 (sFlt-1) protein drives the maternal syndrome observed in PE, and reductions in sFlt-1 improved symptoms. We have previously reported that the bioflavonoid luteolin reduces sFlt-1 expression and the vasoconstrictor endothelin-1 (ET-1) in vitro and dilates uterine arteries ex vivo. Here, we set out to determine whether luteolin reduces mean arterial pressure (MAP), sFlt-1, and ET-1, and improves uterine artery resistance index (UARI) in the reduced uterine perfusion pressure (RUPP) rat model of PE. STUDY DESIGN: On gestation day (GD) 14, animals were randomly separated into 4 groups: sham or RUPP treated with vehicle or luteolin (20 mg/kg/day). On GD19, MAP and UARI were measured, followed by blood and tissue collection. MAIN OUTCOME MEASURES: Placental protein expression of sFlt-1 and HIF-1α (Western blot) and circulating levels of sFlt-1, placental growth factor (PlGF) and ET-1 were measured (ELISA). RESULTS: RUPP animals treated with luteolin demonstrated significant decreases in MAP, UARI, sFlt-1, and ET-1 compared to RUPP animals given a vehicle. There were no differences in sham animals treated with luteolin, and no adverse maternal or fetal outcomes were observed. CONCLUSIONS: Luteolin effectively reduced blood pressure, improved uterine artery flow impedance, and reduced antiangiogenic markers in the RUPP model of PE without any observable adverse effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LuteolinVascular Endothelial Growth Factor Receptor-1IschemiaArterial PressurePre-EclampsiaPlacentaAnimalsFemalePregnancyRatsDisease Models, AnimalUterine ArteryEndothelin-1UterusRats, Sprague-Dawley

Stichwörter der Autor:innen

ET-1HypertensionLuteolinPreeclampsiaRUPPsFlt-1

Substanzen

LuteolinVascular Endothelial Growth Factor Receptor-1Flt1 protein, ratEndothelin-1

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL, USA.
  • Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, MS, USA.
  • Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, MS, USA; School of Biosciences and Biotechnology, Shandong Second Medical University, Weifang, China.
  • Department of Gynecology and Obstetrics, Emory University, Atlanta, GA, USA.
  • Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, MS, USA; Department of Cell and Molecular Biology, University of Mississippi Medical Center, Jackson, MS, USA.
  • Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL, USA. Electronic address: srana@unmc.edu.

Förderung

  • NHLBI NIH HHS
  • NIGMS NIH HHS
  • National Heart Lung and Blood Institute Division of Intramural Research
  • National Heart, Lung, and Blood Institute
  • National Institutes of Health
  • National Institute of General Medical Sciences

Zitieren

APA

Eddy, A. C., Bakrania, B. A., Yang, W., Rajakumar, A., George, E. M., Granger, J. P., & Rana, S. (2026). Luteolin decreases sFlt-1 and mean arterial pressure in the RUPP animal model of placental ischemia. Placenta. https://doi.org/10.1016/j.placenta.2026.06.010

Vancouver

Eddy AC, Bakrania BA, Yang W, Rajakumar A, George EM, Granger JP, et al. Luteolin decreases sFlt-1 and mean arterial pressure in the RUPP animal model of placental ischemia. Placenta. 2026. doi:10.1016/j.placenta.2026.06.010

BibTeX
@article{Eddy2026,
  author = {Eddy, Adrian C and Bakrania, Bhavisha A and Yang, Weiwei and Rajakumar, Augustine and George, Eric M and Granger, Joey P and Rana, Sarosh},
  title = {Luteolin decreases sFlt-1 and mean arterial pressure in the RUPP animal model of placental ischemia},
  journal = {Placenta},
  year = {2026},
  doi = {10.1016/j.placenta.2026.06.010}
}
Kostenlos starten →